Events
2 minute read

Biotechnology Patents at the U.S. Supreme Court: 2012-2013 Term (Live Webinar)

Kevin E. Noonan, Ph.D.July 11, 201310:00 am - 11:15 amLive Webinar via WebEx

MBHB is pleased to conduct a webinar in which the featured presenter, MBHB partner Dr. Kevin E. Noonan, will discuss the outcome of three cases that have been decided by the U.S. Supreme Court this year:




  • Bowman v. Monsanto, a case involving the application of the patent exhaustion doctrine to recombinant soybeans


  • FTC v. Actavis, involving the FTC’s allegations that “reverse payment” settlement agreements between branded and generic drug companies in ANDA litigation are anticompetitive and violate antitrust law


  • Association for Molecular Pathology v. Myriad Genetics, Inc., addressing the question “Are human genes patentable?”

Dr. Noonan will discuss these cases and their effects on the biotechnology industry, particularly in view of recent trends at the Supreme Court regarding the scope of patenting.  He anticipates that the discussion will reference the Supreme Court’s Mayo Collaborative Services v. Prometheus Laboratories, Inc.  decision last term, which reintroduced patent law concepts that have been dormant for half a century.


Dr. Noonan is an MBHB partner who practices biotechnology patent law and is a co-founder of the biotech and pharma weblog Patent Docs.


Presenter: MBHB Partner Kevin E. Noonan, Ph.D. 


While there is no fee to participate, all attendees must register in advance and, in order to receive MCLE credit, must participate individually. Access an archived audio version of this webinar here. NOTE: MCLE credit is not available for this archived recording. 


All registrants will receive an email confirmation and details for online participation. MCLE credit is pending for the states of California, Georgia, Illinois, New Jersey,* New York,* North Carolina and Virginia (*via reciprocity).


McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.